ACM
CSBR icon

ACT Capital Management’s Champions Oncology CSBR Stock Holding History

ACT Capital Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$469K Hold
62,500
– – 0.65% 25
2022
Q2 		$500K Hold
62,500
– – 0.7% 26
2022
Q1 		$508K Hold
62,500
– – 0.54% 32
2021
Q4 		$523K Buy
62,500
+4,000
+7% +$36.8K 0.38% 45
2021
Q3 		$597K Buy
58,500
+8,500
+17% +$86.5K 0.31% 55
2021
Q2 		$514K Buy
+50,000
New +$507K 0.26% 66

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACT Capital Management's CSBR Position: Q3 2022 in Review

ACT Capital Management held its Champions Oncology (CSBR) position steady in Q3 2022 at 62,500 shares worth $469K. The position accounts for 0.65% of the portfolio, ranked #25.

ACT Capital Management first reported a position in CSBR in Q2 2021 and has held it in 6 quarters since. The position peaked at $597K in Q3 2021. 32 funds tracked by Wall St. Rank hold CSBR as of Q3 2022.

  • ACT Capital Management held 62,500 shares of Champions Oncology worth $469K as of Q3 2022.
  • ACT Capital Management left its Champions Oncology share count unchanged in Q3 2022.
  • Champions Oncology made up 0.65% of ACT Capital Management's portfolio in Q3 2022, its #25 holding.
  • ACT Capital Management first reported a position in Champions Oncology in Q2 2021 and has held it in 6 quarters since.
  • ACT Capital Management's Champions Oncology position peaked at $597K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.